Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Regulatory News (SIHL)

Share Price Information for Symphony (SIHL)

Share Price is delayed by 15 minutes
Get Live Data
0.35    -0.002 (-0.57%)
Bid:
0.326
Ask:
0.37
Spread: 0.044 (13.497%)
Market Cap: $179.68m
SIHL Live PriceLast checked at - London Stock Exchange

Intraday Symphony Share Chart

Acquisition

5 May 2016 07:00

RNS Number : 2870X
Symphony International Holdings Ltd
05 May 2016
 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

 

Symphony International Holdings Limited ("Symphony")

 

5 May 2016

  

Acquisition of the Christian Liaigre Group

 

Symphony International Holdings Limited (LSE: SIHL), a leading investor in consumer-related businesses, primarily in the healthcare, hospitality, lifestyle, and real estate sectors is pleased to announce today that it, together along with a co-investor, has entered into an agreement with Bridgepoint Development Capital ("BDC"), a leading European private equity fund, to acquire Financière CL SAS, the holding company of the Christian Liaigre Group ("CLG").

 

Since Christian Liaigre opened his design studio in 1985 in Paris, the Liaigre brand has become synonymous with discreet luxury, and has become one of the most sought-after luxury furniture brands, renowned for its elegant, minimalistic and discreetly luxurious design style. CLG has a strong intellectual property portfolio and provides a range of bespoke furniture, lighting, fabric & leather, and accessories. In addition to operating a network of 26 showrooms in 11 countries across Europe, the US and Asia, CLG undertakes exclusive interior architecture projects for select yachts, hotels, and restaurants and private residences.

 

The opportunity to acquire CLG from BDC was brought to Symphony by its business partner, Chanintr Sirisant, Chairman of Chanintr Living Limited ("CLL"). CLL is a Symphony portfolio company, focused on luxury and affluent brands and is headquartered in Thailand. It is the joint venture partner for CLG in Singapore and the exclusive distributer for Liaigre in Thailand.

 

Anil Thadani, Chairman of Symphony Asia Holdings Private Limited and a Director of Symphony, said:

 

"We are very excited with this opportunity to acquire one of the worlds leading consumer brands. It fits perfectly with our strategy to invest in businesses that are poised to cater to the demographic of rising affluence in Asia and indeed around the world. Symphony, looks forward to working with CLG and supporting Christophe Caillaud, President of CLG, and his team in building the brand with the Liaigre design DNA. We see significant opportunity to grow the brand and existing business, as well as expand into new complementary business areas"

 

 

 

For further information:

Anil Thadani +65 6536 6177

Symphony Asia Holdings Pte. Ltd.

 

About Symphony

Symphony is a London listed strategic investment company that invests in consumer businesses in the healthcare, hospitality and lifestyle ("HH&L") sectors (including branded real estate developments), which are principally in Asia. It offers a way for investors to gain exposure to the rising disposable incomes and wealth in fast growing economies. Symphony's objective is to provide superior capital growth by investing in high quality companies and forming long-term business partnerships with talented entrepreneurs. Symphony is managed by Symphony Asia Holdings Private Limited, which has a team of investment professionals with a broad range of expertise - many of them have been working in Asia for more than 25 years. For more information, please visit our website at www.symphonyasia.com

 

 

No representation or warranty is made by the Company as to the accuracy or completeness of the information contained in this announcement and no liability will be accepted for any loss arising from its use.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Company in any jurisdiction. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decisions.

 

This announcement is not an offer of securities for sale into the United States. The Company's securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

The Company and the Investment Manager are not associated or affiliated with any other fund managers whose names include "Symphony", including, without limitation, Symphony Financial Partners Co., Ltd.

 

End of Announcement

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUGUUAAUPQGQC
Date   Source Headline
29th Apr 20262:16 pmRNSResult of AGM
28th Jan 202611:52 amRNSKey Information Document
27th Jan 202610:15 amRNSDirector/PDMR Shareholding
27th Jan 202610:12 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSNet Asset Value(s)
4th Nov 202511:16 amRNSResponse to Shareholder Correspondence
17th Sep 20257:00 amRNSNet Asset Value(s)
17th Sep 20257:00 amRNSInterim Financial Results
26th Jun 20257:00 amRNSNet Asset Value(s)
30th Apr 202512:08 pmRNSResult of AGM
4th Apr 20259:50 amRNSAnnual Financial Report
4th Apr 20259:49 amRNSNotice of AGM
4th Apr 20259:46 amRNSNet Asset Value(s)
5th Feb 202510:38 amRNSDirector/PDMR Shareholding
5th Feb 202510:37 amRNSDirector/PDMR Shareholding
17th Jan 20252:54 pmRNSDirector/PDMR Shareholding
16th Dec 202410:12 amRNSNet Asset Value(s)
27th Sep 20247:00 amRNSNet Asset Value(s)
27th Sep 20247:00 amRNSInterim Financial Results
28th Jun 202411:46 amRNSNet Asset Value(s)
28th Jun 202411:46 amRNSUpdate on Reporting
30th Apr 202410:45 amRNSResult of AGM
5th Apr 20247:00 amRNSAnnual Financial Report
5th Apr 20247:00 amRNSNotice of Annual General Meeting
20th Mar 20246:17 pmRNSNet Asset Value(s)
20th Mar 20247:00 amRNSPreliminary Results
20th Mar 20247:00 amRNSShareholder Update
1st Feb 202411:15 amRNSDirector/PDMR Shareholding
1st Feb 202411:14 amRNSDirector/PDMR Shareholding
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
14th Dec 202312:25 pmRNSDirector/PDMR Shareholding
11th Dec 20237:00 amRNSNet Asset Value(s)
11th Dec 20237:00 amRNSShareholder Update
16th Nov 20237:00 amRNSKey Information Document
2nd Nov 202311:43 amRNSDirector/PDMR Shareholding
2nd Nov 202311:41 amRNSHolding(s) in Company
1st Nov 20231:27 pmRNSDirector/PDMR Shareholding
1st Nov 20231:26 pmRNSDirector/PDMR Shareholding
26th Oct 202311:15 amRNSDirector/PDMR Shareholding
16th Oct 202311:38 amRNSDirector/PDMR Shareholding
10th Oct 202312:02 pmRNSDirector/PDMR Shareholding
26th Sep 20237:00 amRNSNet Asset Value(s)
26th Sep 20237:00 amRNSShareholder Update
26th Sep 20237:00 amRNSInterim Financial Results
25th Sep 202311:27 amRNSStrategy Update
29th Jun 20237:00 amRNSDividend Declaration
19th Jun 20237:00 amRNSNet Asset Value(s)
19th Jun 20237:00 amRNSShareholder Update
15th May 202311:27 amRNSDirector Update
28th Apr 20233:11 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.